Orantinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Orantinib, covering 2019-08-07 to 2019-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma [Phase 3]